These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 8782646)
1. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Ogretmen B; Safa AR Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
4. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Wu CH; Rastegar M; Gordon J; Safa AR Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825 [TBL] [Abstract][Full Text] [Related]
5. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089 [TBL] [Abstract][Full Text] [Related]
6. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression. De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517 [TBL] [Abstract][Full Text] [Related]
7. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells. Osbild S; Brault L; Battaglia E; Bagrel D Anticancer Res; 2006; 26(5A):3595-600. PubMed ID: 17094488 [TBL] [Abstract][Full Text] [Related]
8. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293 [TBL] [Abstract][Full Text] [Related]
10. [Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells]. Zhao ZL; Cai Y; Wang YY; Xia CL; Li CX; Chen SL; Yang QL; Chen CJ Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 44(4):400-9. PubMed ID: 26555418 [TBL] [Abstract][Full Text] [Related]
11. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062 [TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Teixeira C; Reed JC; Pratt MA Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210 [TBL] [Abstract][Full Text] [Related]
15. Low doses of alpha particle irradiation modify the expression of genes regulating apoptosis in human MCF-7 breast cancer cells. Soto J; Sainz C; González-Lamuño D; Cos S Oncol Rep; 2006 Mar; 15(3):577-81. PubMed ID: 16465415 [TBL] [Abstract][Full Text] [Related]
16. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant. Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313 [TBL] [Abstract][Full Text] [Related]
17. Drug resistant breast cancer cells overexpress ETS1 gene. Kars MD; Işeri OD; Gündüz U Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592 [TBL] [Abstract][Full Text] [Related]
18. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Lotem J; Sachs L Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718 [TBL] [Abstract][Full Text] [Related]
19. ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells. Ciardiello F; Caputo R; Borriello G; Del Bufalo D; Biroccio A; Zupi G; Bianco AR; Tortora G Int J Cancer; 2002 Mar; 98(3):463-9. PubMed ID: 11920601 [TBL] [Abstract][Full Text] [Related]
20. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Hu Y; Xu K; Yagüe E Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]